2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane

C21H34O — CID 171642470

IUPAC2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane
SMILESC[C@]12CCC3C4CCCCC4CCC3C1CCC2CC1CO1
InChIInChI=1S/C21H34O/c1-21-11-10-18-17-5-3-2-4-14(17)6-8-19(18)20(21)9-7-15(21)12-16-13-22-16/h14-20H,2-13H2,1H3/t14?,15?,16?,17?,18?,19?,20?,21-/m1/s1
InChIKeySSXBCDUGXVHLLF-MCCDTNKBSA-N
MW302.50 g/mol
LogP5.43
Rot. Bonds2

About 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane

2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane (PubChem CID 171642470) has the molecular formula C21H34O and a molecular weight of 302.50 g/mol. Its IUPAC name is 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane.

Molecular Properties

Compound Name2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane
PubChem CID171642470
Molecular FormulaC21H34O
Molecular Weight302.50 g/mol
Exact Mass302.26
IUPAC Name2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane
SMILESC[C@]12CCC3C4CCCCC4CCC3C1CCC2CC1CO1
InChIInChI=1S/C21H34O/c1-21-11-10-18-17-5-3-2-4-14(17)6-8-19(18)20(21)9-7-15(21)12-16-13-22-16/h14-20H,2-13H2,1H3/t14?,15?,16?,17?,18?,19?,20?,21-/m1/s1
InChIKeySSXBCDUGXVHLLF-MCCDTNKBSA-N
XLogP5.43
TPSA12.53 Ų
H-Bond Donors
H-Bond Acceptors1
Rotatable Bonds2
Heavy Atoms22
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500302.50
LogP ≤ 55.43
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 101

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane?
The IUPAC name of 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane (CID 171642470) is 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane.
What is the SMILES notation for 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane?
The canonical SMILES for 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane is C[C@]12CCC3C4CCCCC4CCC3C1CCC2CC1CO1.
What is the InChIKey of 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane?
The InChIKey is SSXBCDUGXVHLLF-MCCDTNKBSA-N. The full InChI is InChI=1S/C21H34O/c1-21-11-10-18-17-5-3-2-4-14(17)6-8-19(18)20(21)9-7-15(21)12-16-13-22-16/h14-20H,2-13H2,1H3/t14?,15?,16?,17?,18?,19?,20?,21-/m1/s1.
What are the key properties of 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane?
2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane has a molecular weight of 302.50 g/mol, XLogP of 5.43, 2 rotatable bonds, 0 hydrogen bond donors, and 1 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[(13R)-13-methyl-1,2,3,4,5,6,7,8,9,10,11,12,14,15,16,17-hexadecahydrocyclopenta[a]phenanthren-17-yl]methyl]oxirane is sourced from PubChem (CID 171642470), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).